Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Cryoport Inc (Nasdaq: CYRX) has scheduled its Fourth Quarter and Full Year 2024 financial results announcement for March 4, 2025, after U.S. markets close. The company will release a comprehensive document titled 'Cryoport Fourth Quarter and Full Year 2024 in Review' at 4:05 p.m. ET, providing financial and operational performance details.
Management will host a Q&A conference call at 5:00 p.m. ET the same day, accompanied by a slide deck. The call will be accessible via U.S. dial-in (1-800-717-1738) and International dial-in (1-646-307-1865) with Conference ID 1116296. A webcast replay will be available for a time, and a dial-in replay will be accessible until March 11, 2025.
Cryoport Inc (Nasdaq: CYRX) ha programmato l'annuncio dei risultati finanziari per il Quarto Trimestre e l'Anno Completo 2024 per il 4 marzo 2025, dopo la chiusura dei mercati statunitensi. L'azienda rilascerà un documento completo intitolato 'Cryoport Quarto Trimestre e Anno Completo 2024 in Rassegna' alle 16:05 ET, fornendo dettagli sulle performance finanziarie e operative.
La direzione ospiterà una conferenza telefonica di domande e risposte alle 17:00 ET lo stesso giorno, accompagnata da un insieme di diapositive. La chiamata sarà accessibile tramite numero verde statunitense (1-800-717-1738) e numero internazionale (1-646-307-1865) con ID Conferenza 1116296. Una registrazione della webcast sarà disponibile per un periodo di tempo, e una registrazione telefonica sarà accessibile fino all'11 marzo 2025.
Cryoport Inc (Nasdaq: CYRX) ha programado el anuncio de sus resultados financieros para el Cuarto Trimestre y el Año Completo 2024 para el 4 de marzo de 2025, después del cierre de los mercados en EE. UU. La empresa publicará un documento completo titulado 'Cryoport Cuarto Trimestre y Año Completo 2024 en Revisión' a las 4:05 p.m. ET, proporcionando detalles sobre el rendimiento financiero y operativo.
La dirección llevará a cabo una llamada de conferencia de preguntas y respuestas a las 5:00 p.m. ET el mismo día, acompañada de una presentación. La llamada será accesible a través del número nacional (1-800-717-1738) y el número internacional (1-646-307-1865) con ID de Conferencia 1116296. Una repetición de la transmisión web estará disponible por un tiempo, y una repetición por teléfono estará accesible hasta el 11 de marzo de 2025.
Cryoport Inc (Nasdaq: CYRX)는 2024년 4분기 및 연간 재무 결과 발표를 2025년 3월 4일 미국 시장 종료 후로 예정하고 있습니다. 회사는 16:05 ET에 'Cryoport 2024년 4분기 및 연간 리뷰'라는 제목의 포괄적인 문서를 발표하여 재무 및 운영 성과에 대한 세부 정보를 제공합니다.
경영진은 같은 날 17:00 ET에 슬라이드 자료와 함께 Q&A 전화 회의를 주최할 예정입니다. 이 통화는 미국 다이얼인(1-800-717-1738)과 국제 다이얼인(1-646-307-1865)을 통해 Conference ID 1116296로 접근할 수 있습니다. 웹캐스트 재생은 일정 기간 동안 제공되며, 전화 재생은 2025년 3월 11일까지 접근 가능합니다.
Cryoport Inc (Nasdaq: CYRX) a programmé l'annonce de ses résultats financiers pour le quatrième trimestre et l'année complète 2024 pour le 4 mars 2025, après la fermeture des marchés américains. L'entreprise publiera un document complet intitulé 'Cryoport Quatrième Trimestre et Année Complète 2024 en Revue' à 16h05 ET, fournissant des détails sur les performances financières et opérationnelles.
La direction animera une conférence téléphonique de questions-réponses à 17h00 ET le même jour, accompagnée d'une présentation. L'appel sera accessible via un numéro d'appel américain (1-800-717-1738) et un numéro d'appel international (1-646-307-1865) avec l'ID de conférence 1116296. Une rediffusion de la webdiffusion sera disponible pendant un certain temps, et une rediffusion par téléphone sera accessible jusqu'au 11 mars 2025.
Cryoport Inc (Nasdaq: CYRX) hat die Bekanntgabe seiner finanziellen Ergebnisse für das 4. Quartal und das Gesamtjahr 2024 für den 4. März 2025, nach dem Schließen der US-Märkte, angesetzt. Das Unternehmen wird um 16:05 Uhr ET ein umfassendes Dokument mit dem Titel 'Cryoport 4. Quartal und Gesamtjahr 2024 im Rückblick' veröffentlichen, das Details zur finanziellen und operativen Leistung bereitstellt.
Das Management wird am selben Tag um 17:00 Uhr ET eine Q&A-Konferenzschaltung mit einer Präsentation abhalten. Die Telefonkonferenz ist über die US-Dial-In-Nummer (1-800-717-1738) und die internationale Dial-In-Nummer (1-646-307-1865) mit der Konferenz-ID 1116296 zugänglich. Eine Wiederholung des Webcasts wird für eine gewisse Zeit verfügbar sein, und eine telefonische Wiederholung ist bis zum 11. März 2025 zugänglich.
- None.
- None.
In addition to the earnings release, a document titled "Cryoport Fourth Quarter and Full Year 2024 in Review", providing a review of Cryoport's financial and operational performance and a general business update, will be issued at 4:05 p.m. ET on Tuesday, March 4, 2025. The document is designed to be read in advance of the questions and answers conference call and will be accessible at https://ir.cryoportinc.com/news-events/ir-calendar.
Cryoport management will host a conference call the same day at 5:00 p.m. ET. The conference call will be in the format of a questions and answers session and will address questions members of the investment community have regarding the Company's reported results. A slide deck will accompany the call.
Conference Call Information
Date: | Tuesday, March 4, 2025 |
Time: | 5:00 p.m. ET |
Dial-in numbers: | 1-800-717-1738 ( |
Confirmation code: | Request the "Cryoport Call" or Conference ID: 1116296 |
Live webcast: | 'Investor Relations' section at www.cryoportinc.com or click here. Please allow 10 minutes prior to the call to visit this site to download and install any necessary audio software. |
The questions and answers call will be recorded and available approximately three hours after completion of the live event in the Investor Relations section of the Company's website at www.cryoportinc.com for a limited time. To access the replay of the questions and answers click here. A dial-in replay of the call will also be available to those interested, until March 11, 2025. To access the replay, dial 1-844-512-2921 (
About Cryoport, Inc
Cryoport, Inc. (Nasdaq: CYRX), is a global leader in supply chain solutions for the Life Sciences with an emphasis on cell & gene therapies. Cryoport enables manufacturers, contract manufacturers (CDMO's), contract research organizations (CRO's), developers, and researchers to carry out their respective business with products and services that are designed to derisk services and provide certainty. We provide a broad array of supply chain solutions for the life sciences industry. Through our platform of critical products and solutions including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, we are "Enabling the Future of Medicine™" worldwide, through our innovative systems, compliant procedures, and agile approach to superior supply chain management.
Our corporate headquarters, located in
For more information, visit www.cryoportinc.com or follow via LinkedIn at https://www.linkedin.com/company/cryoportinc or @cryoport on X, formerly known as Twitter at www.x.com/cryoport for live updates.
Forward-Looking Statements
Statements in this press release which are not purely historical, including statements regarding Cryoport's intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that Cryoport's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic and geopolitical conditions, supply chain constraints, inflationary pressures, the effects of foreign currency fluctuations, trends in the products markets, variations in Cryoport's cash flow, market acceptance risks, and technical development risks. Cryoport's business could be affected by other factors discussed in Cryoport's SEC reports, including in the "Risk Factors" section of its most recently filed periodic reports on Form 10-K and Form 10-Q, as well as in its subsequent filings with the SEC. The forward-looking statements contained in this press release speak only as of the date hereof and Cryoport cautions investors not to place undue reliance on these forward-looking statements. Except as required by law, Cryoport disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cryoport-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025-302378679.html
SOURCE Cryoport, Inc.
FAQ
When will Cryoport (CYRX) release its Q4 and Full Year 2024 earnings?
What time is Cryoport's (CYRX) Q4 2024 earnings call?
How can investors access Cryoport's (CYRX) Q4 2024 earnings call?